Cagrilintide: an amylin/calcitonin receptor agonist, administered once a week, with weight loss effects, developed in combination with Sema . The Sema combination, which contains cagrilintide 2.4 mg and sema 2.4 mg, is administered once weekly and has shown potential for glucose-lowering and weight loss in a Phase 2 study.
Product name: |
Cagrilintide |
Appearance: |
Whte powder |
2381089-83-2 |
1415456-99-3 |
Purity: |
99% |
Grade Standard: |
Medicine Grade |
If you have any needs, please feel free to consult us.
Cagrilintide is the first long-acting amylin analog to be studied for weight management. Professor David C W Lau and his team from the Cumming School of Medicine at the University of Calgary in Canada published an article in the top medical journal "The Lancet" A major publication reports the preliminary efficacy and safety tolerability of cagrilintide for weight management in overweight and obese people. The results show that as an auxiliary means of lifestyle intervention, weekly injection of cagrilintide can lead to an average weight loss of up to 11.5 kg after 26 weeks, and is safe and tolerable. It is expected to provide a new solution for weight loss treatment.
A new long-acting amylin agonist, cagrilintide, has shown good efficacy in the treatment of obesity, especially when combined with the highly potent GLP1 receptor agonist sema, with a weight loss potential of more than 20%.
.
Related products
Product Name |
CAS No. |
Product Name |
CAS No. |
Lufenuron |
103055-07-8 |
Toltrazuril |
69004-03-1 |
Nitenpyram |
120738-89-8 |
Praziquantel/Biltricide |
55268-74-1 |
Fenbendazole |
43210-67-9 |
Tetramisole Hcl |
5086-74-8 |
Levamisole |
14769-73-4 |
Ponazuril |
9004-4-2 |
Diclazuril |
101831-37-2 |
Florfenicol |
73231-34-2 |
Albendazole |
54965-21-8 |
Mebendazole |
31431-39-7 |
Ivermectin |
70288-86-7 |
Enrofloxacin Hcl |
112732-17-9 |
RU 58841 |
154992-24-2 |
cb-03-01 |
19608-29-8 |
Biotin |
58-85-5 |
Biotinoyl tripeptide-1 |
299157-54-3 |
Finasteride |
98319-26-7 |
Dutasteride |
164656-23-9 |
Xi'an Xinlu Biotechnology Co., Ltd. is a high-end brand company focusing on the biomedical industry and integrating R&D, production and sales. It has an independent R&D center, advanced laboratory equipment and a professional R&D team, a GMP standard production workshop, a complete set of internationally advanced assembly line equipment, a preparation workshop with a cleanliness level of 100,000, as well as sophisticated testing instruments and scientific testing methods, providing solid technical support for the production of high-quality products. Through long-term R&D, production, and sales practices, it has formed its own unique product line, providing users with products of reliable quality at highly affordable prices. We strictly control quality, ensure the stability of product quality in all aspects, and win the trust of customers with high quality and high-level development.